India · Delayed Price · Currency is INR Windlas Biotech Statistics
Total Valuation
Windlas Biotech has a market cap or net worth of INR 20.50 billion. The enterprise value is 18.07 billion.
| Market Cap | 20.50B |
| Enterprise Value | 18.07B |
Important Dates
The last earnings date was Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | Jul 16, 2026 |
Share Statistics
| Current Share Class | 20.64M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | -0.61% |
| Owned by Insiders (%) | 63.38% |
| Owned by Institutions (%) | 9.16% |
| Float | 7.27M |
Valuation Ratios
The trailing PE ratio is 30.86.
| PE Ratio | 30.86 |
| Forward PE | n/a |
| PS Ratio | 2.18 |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | 55.02 |
| P/OCF Ratio | 19.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.29, with an EV/FCF ratio of 48.48.
| EV / Earnings | 27.19 |
| EV / Sales | 1.92 |
| EV / EBITDA | 17.29 |
| EV / EBIT | 24.29 |
| EV / FCF | 48.48 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.95 |
| Interest Coverage | 13.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.91% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 6.80M |
| Profits Per Employee | 479,740 |
| Employee Count | 1,385 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Windlas Biotech has paid 202.11 million in taxes.
| Income Tax | 202.11M |
| Effective Tax Rate | 23.32% |
Stock Price Statistics
The stock price has decreased by -3.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -3.08% |
| 50-Day Moving Average | 868.25 |
| 200-Day Moving Average | 818.39 |
| Relative Strength Index (RSI) | 66.70 |
| Average Volume (20 Days) | 6,622 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Windlas Biotech had revenue of INR 9.42 billion and earned 664.44 million in profits. Earnings per share was 31.13.
| Revenue | 9.42B |
| Gross Profit | 3.58B |
| Operating Income | 743.96M |
| Pretax Income | 866.55M |
| Net Income | 664.44M |
| EBITDA | 1.02B |
| EBIT | 743.96M |
| Earnings Per Share (EPS) | 31.13 |
Balance Sheet
The company has 2.79 billion in cash and 352.42 million in debt, with a net cash position of 2.44 billion.
| Cash & Cash Equivalents | 2.79B |
| Total Debt | 352.42M |
| Net Cash | 2.44B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.81B |
| Book Value Per Share | 275.20 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 1.05 billion and capital expenditures -676.64 million, giving a free cash flow of 372.70 million.
| Operating Cash Flow | 1.05B |
| Capital Expenditures | -676.64M |
| Depreciation & Amortization | 273.45M |
| Net Borrowing | -940,000 |
| Free Cash Flow | 372.70M |
| FCF Per Share | n/a |
Margins
Gross margin is 37.98%, with operating and profit margins of 7.90% and 7.05%.
| Gross Margin | 37.98% |
| Operating Margin | 7.90% |
| Pretax Margin | 9.20% |
| Profit Margin | 7.05% |
| EBITDA Margin | 10.80% |
| EBIT Margin | 7.90% |
| FCF Margin | 4.12% |
Dividends & Yields
This stock pays an annual dividend of 6.30, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | 6.30 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | 8.62% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.08% |
| Earnings Yield | 3.24% |
| FCF Yield | 1.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |